Table 3.
Control (%) | HD (%) | p Value | |
---|---|---|---|
2–6 M | 66.7 * | 43.1 § | 0.02 |
3–3 W | 35.0 † | 29.0 ¶ | 0.66 |
3–3 M | 37.2 ‡ | 24.2 ‖ | 0.19 |
2–6 M: 6 months after the primary series. 3–3 W: 3 weeks after the booster dose. 3–3 M: 3 months after the booster dose. COVID-19: coronavirus disease 2019. HD: Hemodialysis. * n = 45; † n = 40; ‡ n = 43; § n = 65; ¶ n = 63; ‖ n = 62. The correlations between the T-SPOT results and antibody titers of each of the three measurement points in each group were evaluated (Figure 4). No significant correlations were observed at 6 months after the primary series, 3 weeks after the booster dose, or 3 months after the booster dose.